How can farmers of aquatic animals quickly select the best stocks for breeding? Benjamin Renquist, PhD, answered this challenge by inventing an assay that works for fish, mollusks and crustaceans alike. The technology has been licensed to startup GenetiRate.

On October 3 and 4, 2018, in Phoenix, Arizona, White Hat Investors will be holding its annual luncheon. Of the 32 companies who will be presenting during the two-day event, five are UA startups.

After thirty-two years of working for the University of Arizona, Associate Vice President Bruce A. Wright, who brought a new tech-based vision for the economy to the University and our community is retiring from Tech Parks Arizona.

Hermelinda Bristol, mother of Jeffrey Bristol who has cerebral palsy, has developed a supportive, non-motorized exoskeleton to help Jeffrey walk without assistance. With TLA's help, the design is now available to help others.

UA inventors have developed a system that interviews border crossers, monitors thousands of signals from the voice, body and eyes, and alerts agents when it detects deception. Meet the AVATAR, now licensed to Discern Science International, Inc.

For FY2018, the UA has again met or surpassed performance expectations for technology commercialization as TLA continues to bring University inventions from the lab to the world for social and economic benefit. Now, it's time to look forward.

In optical communications such as those that drive the Internet, modulators are essential. Robert Norwood, Ph.D. and Nasser Peyghambarian, Ph.D., collaborated to create a new electro-optic waveguide modulator with low insertion loss.

Anthony Muscat, Ph.D., is developing a process to deposit a very thin coating of metal using metal nanoparticles by only the electrostatic interaction between the nanoparticles and a suitably prepared substrate surface like silica, glass or other metals. Check out the blog and video.

Tucson's newest early-stage capital fund, UA Venture Capital Fund LLC, has announced that it's first investments will be in three UA-connected companies: startups Codelucida, Regulonix and Post.Bid.Ship.

As cancer diagnostics and therapeutics become more personalized, pathologists will require more high-quality tissue from biopsies for testing. To address the challenge, this startup is working to bring a next-generation biopsy instrument invented at the UA to the world.